Both in Pharmaceuticals
Acurx Pharmaceuticals vs Aprea Therapeutics
Over the past year ACXP returned −81.2% and APRE returned −66.0%; their daily moves had a correlation of 0.02.
ACXP −81.2% APRE −66.0%Growth of $1, one year, split-adjusted
| Metric | ACXP | APRE |
|---|---|---|
| Price | $1.07 | $0.4936 |
| Market cap | $5.9M | $6.2M |
| Today | 0.00% | −8.22% |
| 1 month | −15.1% | −34.2% |
| 6 months | −50.5% | −38.3% |
| Year to date | −57.0% | −42.1% |
| 1 year | −83.0% | −65.2% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,198.6× |
| Net cash | $10.7M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 60.1% | 95.7% |
| Short % of float | 1.8% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).